Variations in platelet 5-hydroxytryptamine in control and depressed populations

Area of Science:

• Neuroscience
• Psychiatry
• Chronobiology

Background:

• Platelet 5-hydroxytryptamine (serotonin) uptake is a biomarker studied in depression.
• Circadian rhythms influence physiological processes, including neurotransmitter systems.

Purpose of the Study:

• To investigate circadian rhythmicity of platelet serotonin uptake in depressed patients compared to controls.
• To determine if antidepressant treatment normalizes disrupted circadian patterns in depression.

Main Methods:

• Measured platelet 5-hydroxytryptamine uptake at multiple time points throughout the day.
• Compared uptake patterns in 28 endogenously depressed patients and 20 healthy controls.
• Assessed changes before, during, and after antidepressant treatment.

Main Results:

• Control subjects exhibited circadian variation in platelet serotonin uptake.
• Depressed patients lacked this normal daily variation.
• Clinical responders showed restoration of circadian variation, independent of changes in uptake affinity.
• Non-responders and patients early in treatment did not show this restoration.

Conclusions:

• Depression is associated with a disruption of circadian rhythms.
• Abnormalities in platelet serotonin uptake in depression appear secondary to circadian disruption.
• Antidepressants may exert therapeutic effects by correcting these circadian rhythm disturbances.